Multi-contrast Versus Multi-sequence Carotid MRI
Recruiting
Observational Study
Atherosclerosis
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 40 (estimated)
- Sponsor
- Maastricht University Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The objective of this study is to validate 2 multi-contrast sequences, namely the Multi-contrast ATherosclerosis Characterization (MATCH) and Bright-blood and black-blOOd phase SensiTive (BOOST) inversion recovery sequence for the quantification of atherosclerotic plaque components with conventional multi-sequence MRI and histology.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
In order to be eligible to participate in this study, a subject must meet the following criteria:
* Patients with a carotid plaque ≥ 2 mm thick based on ultrasound or CTA
* Age 18 years or older (no maximum age)
* Informed consent by signing informed consent form regarding this…
Contacts
No contact information available.